source
- Radiology practices increasingly develop and market in-house AI, branding themselves as AI-nativeRadiology groups, especially outpatient and teleradiology firms, are moving beyond using third‑party AI tools and are building their own algorithms within the practice. By keeping development in‑h…
- Sarepta Therapeutics agrees to pay $39 million to settle gene therapy dispute with RegenxbioSarepta Therapeutics has agreed to resolve a dispute with Regenxbio by paying $39 million. The payment settles claims related to gene therapy technology that both companies have been developing.…